133 related articles for article (PubMed ID: 9097986)
1. Comparative effects of beta2-adrenergic agonists on muscle waste associated with tumour growth.
Carbó N; López-Soriano J; Tarragó T; González O; Llovera M; López-Soriano FJ; Argilés JM
Cancer Lett; 1997 May; 115(1):113-8. PubMed ID: 9097986
[TBL] [Abstract][Full Text] [Related]
2. Anabolic effects of the beta 2-adrenoceptor agonist salmeterol are dependent on route of administration.
Moore NG; Pegg GG; Sillence MN
Am J Physiol; 1994 Sep; 267(3 Pt 1):E475-84. PubMed ID: 7943228
[TBL] [Abstract][Full Text] [Related]
3. Alteration of trabecular bone under chronic beta2 agonists treatment.
Bonnet N; Brunet-Imbault B; Arlettaz A; Horcajada MN; Collomp K; Benhamou CL; Courteix D
Med Sci Sports Exerc; 2005 Sep; 37(9):1493-501. PubMed ID: 16177600
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the effects of salbutamol and clenbuterol on skeletal muscle mass and carcass composition in senescent rats.
Carter WJ; Lynch ME
Metabolism; 1994 Sep; 43(9):1119-25. PubMed ID: 7916118
[TBL] [Abstract][Full Text] [Related]
5. Severe bone alterations under beta2 agonist treatments: bone mass, microarchitecture and strength analyses in female rats.
Bonnet N; Benhamou CL; Brunet-Imbault B; Arlettaz A; Horcajada MN; Richard O; Vico L; Collomp K; Courteix D
Bone; 2005 Nov; 37(5):622-33. PubMed ID: 16157516
[TBL] [Abstract][Full Text] [Related]
6. Enhanced leucine oxidation in rats bearing an ascites hepatoma (Yoshida AH-130) and its reversal by clenbuterol.
Costelli P; Llovera M; García-Martínez C; Carbó N; López-Soriano FJ; Argilés JM
Cancer Lett; 1995 May; 91(1):73-8. PubMed ID: 7750097
[TBL] [Abstract][Full Text] [Related]
7. Muscle protein waste in tumor-bearing rats is effectively antagonized by a beta 2-adrenergic agonist (clenbuterol). Role of the ATP-ubiquitin-dependent proteolytic pathway.
Costelli P; García-Martínez C; Llovera M; Carbó N; López-Soriano FJ; Agell N; Tessitore L; Baccino FM; Argilés JM
J Clin Invest; 1995 May; 95(5):2367-72. PubMed ID: 7738199
[TBL] [Abstract][Full Text] [Related]
8. Beta adrenoceptor agonists, clenbuterol, and isoproterenol retard denervation atrophy in rat gastrocnemius muscle: use of 3-methylhistidine as a marker of myofibrillar degeneration.
Agrawal S; Thakur P; Katoch SS
Jpn J Physiol; 2003 Jun; 53(3):229-37. PubMed ID: 14529584
[TBL] [Abstract][Full Text] [Related]
9. Effects of the beta 2-adrenoceptor agonist, clenbuterol, on muscle atrophy due to food deprivation in the rat.
Choo JJ; Horan MA; Little RA; Rothwell NJ
Metabolism; 1990 Jun; 39(6):647-50. PubMed ID: 1693748
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of dexamethasone and clenbuterol on rat growth and on beta2-adrenoceptors in lung and skeletal muscle.
Huang H; Gazzola C; Pegg GG; Sillence MN
J Anim Sci; 2000 Mar; 78(3):604-8. PubMed ID: 10764067
[TBL] [Abstract][Full Text] [Related]
11. Systemic administration of beta2-adrenoceptor agonists, formoterol and salmeterol, elicit skeletal muscle hypertrophy in rats at micromolar doses.
Ryall JG; Sillence MN; Lynch GS
Br J Pharmacol; 2006 Mar; 147(6):587-95. PubMed ID: 16432501
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-15 antagonizes muscle protein waste in tumour-bearing rats.
Carbó N; López-Soriano J; Costelli P; Busquets S; Alvarez B; Baccino FM; Quinn LS; López-Soriano FJ; Argilés JM
Br J Cancer; 2000 Aug; 83(4):526-31. PubMed ID: 10945502
[TBL] [Abstract][Full Text] [Related]
13. beta-Adrenergic receptor agonists increase apoptosis of adipose tissue in mice.
Page KA; Hartzell DL; Li C; Westby AL; Della-Fera MA; Azain MJ; Pringle TD; Baile CA
Domest Anim Endocrinol; 2004 Jan; 26(1):23-31. PubMed ID: 14732450
[TBL] [Abstract][Full Text] [Related]
14. Effects of the beta 2-adrenergic agonist clenbuterol on capillary geometry in cardiac and skeletal muscles in young and middle-aged rats.
Suzuki J; Gao M; Xie Z; Koyama T
Acta Physiol Scand; 1997 Nov; 161(3):317-26. PubMed ID: 9401584
[TBL] [Abstract][Full Text] [Related]
15. beta2-adrenoceptor agonists reduce the decline of rat diaphragm twitch force during severe hypoxia.
van der Heijden HF; Heunks LM; Folgering H; van Herwaarden CL; Dekhuijzen PN
Am J Physiol; 1999 Mar; 276(3):L474-80. PubMed ID: 10070112
[TBL] [Abstract][Full Text] [Related]
16. Formoterol fumarate and roxithromycin effects on muscle mass in an animal model of cancer cachexia.
Kenley RA; Denissenko MF; Mullin RJ; Story J; Ekblom J
Oncol Rep; 2008 May; 19(5):1113-21. PubMed ID: 18425366
[TBL] [Abstract][Full Text] [Related]
17. Metabolic responses to BRL37344 and clenbuterol in soleus muscle and C2C12 cells via different atypical pharmacologies and beta2-adrenoceptor mechanisms.
Ngala RA; O'Dowd J; Wang SJ; Agarwal A; Stocker C; Cawthorne MA; Arch JR
Br J Pharmacol; 2008 Oct; 155(3):395-406. PubMed ID: 18552870
[TBL] [Abstract][Full Text] [Related]
18. Anabolic beta-2-agonist clenbuterol fails to modify muscle atrophy due to femur fracture.
Choo JJ; Horan MA; Little RA; Rothwell NJ; Wareham A
Circ Shock; 1990 Oct; 32(2):165-71. PubMed ID: 1701362
[TBL] [Abstract][Full Text] [Related]
19. Nifedipine does not impede clenbuterol-stimulated muscle hypertrophy.
Murphy RJ; Béliveau L; Gardiner PF; Calderone A
Proc Soc Exp Biol Med; 1999 Jul; 221(3):184-7. PubMed ID: 10404034
[TBL] [Abstract][Full Text] [Related]
20. Effects of clenbuterol and ICI118551, a selective beta 2-antagonist, on the growth of skeletal muscle of suckling rats.
Morton RH; Agbenyega ET; Hatton PA; Wareham AC
Pflugers Arch; 1995 Dec; 431(2):237-43. PubMed ID: 9026784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
